(RTTNews) - Fresenius SE & Co. KGaA (FRE.DE), a health care company, on Thursday announced that it has acquired the remaining 45% stake in mAbxience Holding S.L. for up to 750 million euros.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.